Application of zinc-luteolin composite material in inhibition of enteritis serotype of salmonella subsp. Enteroides
The coordination reaction of zinc-luolin composite material generates spherical nanoparticles, destroying the cell membrane of Salmonella enteric, solving the problems of contamination and infection of Salmonella enteric, achieving low-cost and efficient antibacterial effects, and avoiding drug resistance problems .
Patent Information
- Application Number
- CN202411051316.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-01
- Publication Date
- 2024-11-19
AI Technical Summary
The prior art is difficult to effectively inhibit the contamination and infection of the serotype of enteritis of Salmonella enterogenic intestinal subspecies. The use of traditional antibiotics will lead to increased drug resistance and have a negative impact on food quality and human health.
The zinc-luolin composite material is used to generate spherical nanoparticles through coordination reactions, which are used to inhibit the cell membrane potential changes of the enteritis serotype of Salmonella enterogenic intestinal subspecies, destroy their cell membrane integrity, and thus achieve inhibition and killing effects.
Zinc-luolin composites show low-cost and efficient antibacterial effects, can effectively inhibit the growth and killing of Salmonella enteric bacteria, and are not easy to lead to bacterial resistance, and have safety and wide application prospects.
Smart Images

Figure HDA0004975012250000011 
Figure HDA0004975012250000012 
Figure HDA0004975012250000013
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of food and medicine, and relates to the application of a zinc-luteolin composite material in the preparation of a preservative and a medical antibacterial agent. Background Art
[0002] Microbial contamination is an important cause of food spoilage. If microbial contamination cannot be prevented and controlled at an early stage, it will not only affect food quality, but also the health of consumers. At present, food picking, preservation, and storage use antibacterial drugs and high-temperature sterilization to achieve the purpose of antibacterial. However, the large amount of antibiotics, preservatives and other additives added for this purpose will cause changes in food quality, and will also cause microorganisms to develop or increase drug resistance. Some preservatives will have harmful effects on the human body; and high-temperature sterilization has a certain impact on food quality and taste.
[0003] Salmonella enterica subsp. enterica serovar Enteritidis is a gram-negative rod of the genus Salmonella, with a size of 0.6-2.0 μm × 1.0-4.0 μm, and usually moves with peritrichous flagella. Salmonella enterica subsp. enterica serovar Enteritidis often infects poultry and livestock, and exists in related foods, especially meat products and milk, thus causing food poisoning. The Salmonella enterica subspecies enteritidis serotype isolated from sick humans and animals showed a certain degree of resistance to antibiotics; for example, 72.7% of the isolated strains showed multidrug resistance (≥3 antibiotics), with polymyxin B having the highest resistance rate (81.8%), followed by nalidixic acid (72.7%), colistin (59.1%), ampicillin / tetracycline (45.5%), ampicillin-sulbactam (40.9%), ceftriaxone (18.2%), streptomycin (9.1%) and ceftazidime / cefotaxime-tazobactam (4.5%). In addition to antibiotic treatment, the current inhibitory measures for Salmonella enterica subspecies enteritidis serotype include the use of the antioxidant properties of the essential oil linalool and vitamin C and copper (LVC) to combat the pathogenicity of foodborne pathogens Salmonella enterica subspecies enteritidis, which has a certain effect.
[0004] Phenolic acid plays an antioxidant role mainly by directly scavenging reactive oxygen species (ROS), directly or indirectly inhibiting lipid peroxidation, and chelating with metal ions. Its antibacterial effect is affected by many factors, such as the chemical structure of phenolic acid and the number of functional groups. The antibacterial mechanism of phenolic acid includes: destroying the barrier function of cell wall and cell membrane, increasing membrane permeability, causing leakage of microbial intracellular components and affecting the stability of cell structure; blocking metabolism through energy metabolism system, leading to bacterial death; combining with microbial genetic material and changing microbial physiology, making cells lose the basis for growth and reproduction, thereby inhibiting their growth; and achieving antibacterial effect by acidification of cytoplasm, causing protein denaturation, producing antimicrobial activity.
[0005] Metal polyphenol complexes have gradually developed in the application of antibacterial and antitumor medicine. For example, studies have shown that the metal polyphenol complexes composed of grafted chlorogenic acid (CA-ECS), oxidized pullulan (OP) and zinc ions (Zn 2+ ) of chitosan skeleton, the hydrogel can be 2+ and CA improved the mechanical properties and antioxidant and antibacterial activities, and in the rat skin wound model infected with Staphylococcus aureus, CA-ECS / OP / Zn 2+ Hydrogels show good anti-inflammatory, angiogenic and folliculogenic properties, thereby accelerating wound healing (see: Yun Duan, Fuchen Jiang, Qing Li, Arlene McDowell, Yingxi Li, YingWang, Shuang Liu, Chen Zhang, Xiaoli Pan. Multifunctional polysaccharide / metal / polyphenol double crosslinked hydrogel for infected wound. Carbohydrate Polymers, Volume 332, 2024, 121912, ISSN 0144-8617, https: / / doi.org / 10.1016 / j.carbpol.2024.121912.). However, this type of complex has complex components and easily changeable physical and chemical properties, and is not suitable for use as a preservative.
[0006] Luteolin is a natural product with a molecular formula of C 15 H 10O6, molecular weight is 286.23; CAS number is 491-70-3. Luteolin exists in many plants and has a variety of pharmacological activities, such as anti-inflammatory, anti-allergic, uric acid lowering, anti-tumor, antibacterial, antiviral, etc. Zinc acetate, also known as zinc acetate, is an organic salt with a chemical formula of (CH3COO)2Zn. Zinc acetate can be obtained by reacting zinc oxide with acetic acid. Medicines containing 30% zinc acetate are often used as zinc supplements. In addition, zinc acetate tablets can also be used in the clinical treatment of genetic diseases. At present, nano zinc oxide is often used for the antibacterial application of zinc, and luteolin has a certain antibacterial effect on Escherichia coli, etc., but there are no reports on the use of composite materials prepared by reacting with metals to inhibit and kill Salmonella enterica subspecies enteritis serotype, and its application in related food and new antibacterial agents in medicine. Summary of the invention
[0007] The purpose of the present invention is to provide an application of a zinc-luteolin composite material in inhibiting Salmonella enterica subspecies enteritidis serotype, so as to solve the problem of food poisoning and illness caused by contamination or infection by foodborne pathogens such as Salmonella enterica subspecies enteritidis serotype.
[0008] In order to achieve the above object, the present invention adopts the following technical solutions:
[0009] In the first aspect, a zinc-luteolin composite material is provided for use in the preparation of a drug for inhibiting foodborne pathogens, wherein the zinc-luteolin composite material inhibits the growth of Salmonella enteritidis (i.e., the zinc-luteolin composite material is an effective pharmaceutical ingredient that has an inhibitory effect on foodborne pathogens such as Salmonella enteritidis).
[0010] Preferably, the Salmonella Enteritidis is an isolated strain of Salmonella Enteritidis subspecies Enteritidis serotype that exists in food and eventually causes food poisoning.
[0011] Preferably, the minimum inhibitory concentration of the zinc-luteolin composite material against Salmonella enterica subspecies enteritidis serotype CICC 21513 is 31.25 μmol / L.
[0012] Preferably, the zinc-luteolin composite material causes a change in the cell membrane potential of Salmonella enterica subspecies enteritidis serotype, thereby depolarizing and damaging the cell membrane, thereby exerting an inhibitory and killing effect on Salmonella enterica subspecies enteritidis serotype; that is, the zinc-luteolin composite material can be used as the main active ingredient of a drug to exert antibacterial and bactericidal effects.
[0013] Preferably, the zinc-luteolin composite material damages the bacterial integrity of Salmonella enterica subspecies enteritidis serotype, such as bacterial deformation (caused by changes in surface morphology), shrinkage, and accelerates bacterial death as the cell membrane is damaged.
[0014] Preferably, the drug further comprises other ingredients having anti-Salmonella enterica subspecies enteritidis serotype activity (ie, other active ingredients of the drug) that can be combined with the zinc-luteolin composite material.
[0015] Preferably, the medicine further comprises preparation excipients.
[0016] Preferably, the zinc-luteolin composite material is prepared by complexing zinc ions and luteolin via a coordination reaction.
[0017] Preferably, the compounding specifically comprises the following steps: under weak alkaline conditions (such as pH 7.8-8.0), zinc acetate and luteolin added in a certain proportion (such as the chemical reaction molar ratio of zinc acetate to luteolin is 1-3:1) are reacted in a solvent (such as water) by continuous heating and stirring (such as reacting at 55-65°C for 4-5h), and a zinc-luteolin complex with a corresponding coordination ratio dispersed in the reaction system can be obtained (in the reaction, zinc acetate dissociates to form acetate and zinc ions, and the zinc ions formed after the dissociation of zinc acetate are combined with the luteolin after the hydrogen ions are removed through coordination bonds, and the generated spherical nanoparticles are the zinc-luteolin complex).
[0018] In a second aspect, the invention provides the use of the zinc-luteolin composite material in the preparation of food additives (such as preservatives).
[0019] In a third aspect, the invention provides the use of the zinc-luteolin composite material in the preparation of feed additives (such as preservatives).
[0020] Preferably, the food additive or feed additive is used to inhibit the reproduction of Salmonella enteritidis (such as Salmonella enteritidis subspecies enteritidis serotype) on the surface of food or feed.
[0021] The beneficial effects of the present invention are embodied in:
[0022] In the pharmacological and related drug toxicity experiments conducted around the use of metal phenolic acid composite products to inhibit food-borne pathogens such as Salmonella enterica (such as Salmonella enterica subspecies enterica serotype), the present invention discovered and verified the effective ingredients that can exert antibacterial activity against such food-borne pathogens, that is, the zinc-luteolin composite material is applied in the preparation of pharmaceutical antibacterial agents and preservatives to prevent food poisoning and related infectious diseases caused by contamination of Salmonella enterica. In addition, the zinc-luteolin composite material has the advantages of low cost and high efficiency in antibacterial applications (such as food preservation, storage, etc.).
[0023] Furthermore, the present invention determines the minimum inhibitory concentration (MIC) of the zinc-luteolin composite material against Salmonella enterica subspecies enteritidis serotype through a mixed co-culture plate coating method, which not only provides a basis for using the zinc-luteolin composite material as an antibacterial substance with broad market prospects, but also provides a reference for the application research of related products.
[0024] Furthermore, the present invention has found through experiments that as the concentration of the zinc-luteolin composite material increases, it can destroy the integrity of the cell membrane of the Salmonella enterica subspecies enteritidis serotype strain (mainly referring to morphological deformation and shrinkage) and the stability of the cell membrane surface potential (i.e., membrane potential), not only inhibiting the growth of Salmonella enterica subspecies enteritidis serotype, but also having a certain killing effect on Salmonella enterica subspecies enteritidis serotype. BRIEF DESCRIPTION OF THE DRAWINGS
[0025] Figure 1a This is a scanning electron microscope image of the material: zinc-luteolin composite material after cleaning and drying.
[0026] Figure 1b This is the EDS spectrum of the material: zinc-luteolin composite material after washing and drying (the element distribution of this material is different from that of the raw material zinc acetate).
[0027] Figure 2 This is the dot plate diagram of the inhibition experiment of zinc-luteolin composite material, luteolin and zinc acetate on Salmonella enterica subspecies enteritidis serotype (CK is the blank group).
[0028] Figure 3 The bacterial plate images after co-culture with different drug concentrations obtained by the co-culture plate coating method (CK is the blank group; sterile glass beads are used for coating; luteolin gradient 9, that is, the colonies have grown completely after co-culture with 7.8125 μM drug concentration).
[0029] Figure 4 Electron microscopic images of Salmonella enterica subspecies Enteritidis serotype strains under the action of different concentrations of luteolin, zinc acetate, and zinc-luteolin composite material (CK is the blank group).
[0030] Figure 5 This is a statistical diagram of the changes in cell membrane potential of Salmonella enterica serotype Enteritidis subspecies after the action of zinc-luteolin composite material (CK is the blank group; **P<0.01).
[0031] Figure 6 The results are shown in Figure 2. DETAILED DESCRIPTION
[0032] The present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. The embodiments are only for explanation of the present invention, but not for limiting the protection scope of the present invention.
[0033] (I) Preparation of zinc-luteolin composite materials
[0034] Taking luteolin and zinc acetate as basic raw materials, a zinc-luteolin composite material with a spherical nanostructure is obtained by stirring and heating in a weakly alkaline environment, as described below:
[0035] The reaction was carried out in a reaction bottle with a certain volume capacity. After adding analytically pure reaction raw materials zinc acetate (4000 μM) and luteolin (the chemical reaction molar ratio of zinc acetate: luteolin, i.e., the amount of substance was 2:1) to ultrapure water, 1 mol / L NaOH solution was used to adjust the reaction environment pH=8. After adjusting the pH, the reaction system in the reaction bottle was heated to a reaction temperature of 55°C until the reaction was completed after 4 hours, and the reaction was continuously stirred during the reaction (the speed was 500 r / min). After the reaction was completed, the heating and stirring were stopped, and the reaction system (in the form of a suspension) was centrifuged at 8000g (room temperature) for 10min to preliminarily separate the solid after the reaction. The solid was washed alternately with anhydrous ethanol and ultrapure water 4 times, and centrifuged at 8000g (room temperature) for 10min after each washing, and finally dried in a 45°C vacuum drying oven to obtain a solid powder.
[0036] See also Figure 1a The obtained solid powder was sampled by electron microscopy, and a large number of spherical nanoparticles of zinc-luteolin complex in a stacked state were observed by scanning electron microscopy.
[0037] See also Figure 1b The obtained solid powder was detected by EDS energy dispersive spectrometer, and the results verified that the zinc-luteolin composite material was formed by the complex of luteolin and zinc ions (the presence of Zn in the composite material represents that the zinc-luteolin complex was successfully synthesized).
[0038] (II) Experiment on the inhibitory effect of zinc-luteolin composite material on Salmonella enterica subspecies enteritidis serotype
[0039] The minimum inhibitory concentration of the zinc-luteolin composite material against the enteric serotype of Salmonella enterica subspecies enteritidis strain was determined by the co-culture plate coating method, and the enteric serotype of Salmonella enterica subspecies enteritidis strain after the action of the zinc-luteolin composite material was further observed by scanning electron microscopy; the specific instructions are as follows.
[0040] 2.1 Experimental strains
[0041] Salmonella enterica subsp. enterica serovar Enteritidis, strain number CICC 21513, was purchased from China Culture Collection Center.
[0042] 2.2 Culture medium
[0043] LB liquid culture medium: Tryptone 10 g / L, yeast extract 5 g / L, and sodium chloride (NaCl) 10 g / L, pH adjusted to 7.4, and sterilized at 121°C for 20 min.
[0044] LB solid medium: Add 15g / L agar to LB liquid medium.
[0045] 2.3 Comparison of antibacterial properties of zinc acetate, luteolin, and zinc-luteolin composite materials by bacterial colony growth after plating with mixed co-cultured bacterial solution
[0046] The purchased strains were activated on LB solid medium by streaking, and a single colony was picked and inoculated into LB liquid medium. The first generation of bacteria was activated by shaking culture at 37°C for 12-14 hours. Then 100 μL of the first generation of bacteria was inoculated into a sterile shaking bottle containing 30 mL of LB liquid medium and cultured for about 4 hours. The concentration of the bacterial solution was determined to be 1×10 8 After the CFU / mL, 1mL of bacterial solution was drawn into different centrifuge tubes according to the set drug gradient, centrifuged at 8000g (room temperature) for 5min to remove the culture solution, and washed the bacterial precipitate twice with sterilized saline, and finally resuspended with 1mL of the corresponding gradient zinc-luteolin composite solution; according to the same operation steps, 1mL of zinc acetate solution and luteolin solution with the same gradient were used to prepare the resuspended bacterial solution and used as a control; in addition, 1mL of physiological saline was used to prepare the blank group resuspended bacterial solution. After co-culture for 4h (37℃ shaker), 3μL of the bacterial solution treated with different drug solutions in each group was drawn according to each gradient and plated on LB solid culture medium, and the blank group bacterial solution was plated at the same time, and cultured at 37℃ for 12 hours to observe the growth of colonies.
[0047] The preparation of the above solutions is described as follows (the concentrations of the solutions are shown in Table 1): luteolin and zinc acetate are prepared separately with physiological saline to form luteolin suspension and zinc acetate solution; the zinc-luteolin composite material solution is obtained by resuspending the powder in physiological saline.
[0048] Table 1. Luteolin, zinc acetate, zinc-luteolin composite material spot plate solution gradient
[0049] Solution concentration Luteolin(μM) Zinc acetate(μM) Zinc-luteolin composite material (μM) Gradient 1 2000 2000 2000 Gradient 2 1000 1000 1000 Gradient 3 500 500 500 Gradient 4 250 250 250 Gradient 5 125 125 125 Gradient 6 62.5 62.5 62.5 Gradient 7 31.25 31.25 31.25 Gradient 8 15.625 15.625 15.625 Gradient 9 7.8125 7.8125 7.8125 Gradient 10 3.90625 3.90625 3.90625 Gradient 11 1.953125 1.953125 1.953125
[0050] Note: All drug solutions were prepared with physiological saline as solvent; the “zinc-luteolin composite material” specifically used the zinc-luteolin composite material prepared in (I).
[0051] from Figure 2It can be seen that the zinc-luteolin composite material has good antibacterial properties against Salmonella enterica subspecies enteritidis serotype, and is significantly better than luteolin and zinc acetate.
[0052] 2.4 Determination of the minimum inhibitory concentration (MIC) of zinc-luteolin composite materials against Salmonella enterica subspecies enteritidis serotype
[0053] Pick a single colony of the purchased strain and inoculate it into LB liquid medium, incubate it at 37℃ for 12-14 hours, and save it as the first generation of bacteria. Transfer the first generation of bacteria to LB liquid medium and incubate it at 37℃ for about 4 hours until the concentration of the bacterial solution is 1×10 8 CFU / mL, the minimum inhibitory concentration (MIC) of the zinc-luteolin composite material prepared in (I) was determined according to the co-culture plate coating method.
[0054] Co-culture plate spreading method: the concentration is 1×10 8 1 mL of the bacterial solution with CFU / mL was drawn into a 1.5 mL centrifuge tube, centrifuged at 8000g (room temperature) for 5 min to remove the culture medium, and washed three times with sterile saline by centrifugation. Finally, 1 mL of different gradient drug solutions (a total of 12 gradients, the drug solution concentrations are shown in Table 2, and the drug solution was diluted with sterile saline) was added, and the blank group was resuspended with 1 mL of sterile saline. After 4 hours of co-culture (37°C shaker), 50 μL was drawn according to each gradient and the drawn bacterial solution was spread on LB solid culture medium, and the culture was kept in a 37°C incubator for 10 hours to observe the growth of the colonies. In order to exclude other factors and better confirm the antibacterial properties of the zinc-luteolin composite material, the same gradient drug solution was divided into three groups, namely: luteolin, zinc acetate, and zinc-luteolin composite material, with three parallels in each group. MIC is defined as the lowest drug concentration at which bacterial growth can be detected.
[0055] Table 2. Luteolin, zinc acetate, zinc-luteolin composite material coating solution gradient
[0056] Solution concentration Luteolin(μM) Zinc acetate(μM) Zinc-luteolin composite material (μM) Gradient 1 2000 2000 2000 Gradient 2 1000 1000 1000 Gradient 3 500 500 500 Gradient 4 250 250 250 Gradient 5 125 125 125 Gradient 6 62.5 62.5 62.5 Gradient 7 31.25 31.25 31.25 Gradient 8 15.625 15.625 15.625 Gradient 9 7.8125 7.8125 7.8125 Gradient 10 3.90625 3.90625 3.90625 Gradient 11 1.953125 1.953125 1.953125 Gradient 12 0.9765625 0.9765625 0.9765625
[0057] See also Figure 3 When the concentration is gradient 7, that is, the concentration of the zinc-luteolin composite material solution is 31.25μM, the zinc-luteolin composite material has an inhibitory effect on the Salmonella enterica subspecies enteritidis serotype strain CICC 21513 (no colonies grow on the plate corresponding to the concentration of the solution). It can be concluded that the MIC value of the zinc-luteolin composite material against the Salmonella enterica subspecies enteritidis serotype can be as low as 31.25μM.
[0058] 2.5 Observation of the inhibitory effect of zinc-luteolin composite material on Salmonella enterica subspecies enteritidis serotype strains using scanning electron microscopy
[0059] The first generation bacteria were transferred to LB liquid medium and cultured at 37°C in a shaking incubator for about 4 hours until the bacterial solution reached the logarithmic growth phase with a concentration of 1×10 8 CFU / mL, the bacterial solution was centrifuged at 8000rpm (room temperature) for 5min, the supernatant was removed, and the bacterial precipitate was washed with sterile saline. Then, 1mL of zinc-luteolin composite suspension prepared with sterile saline as solvent and the concentrations of 2MIC, 1MIC and 1 / 2MIC were added and resuspended as different concentrations of zinc-luteolin composite treatment groups, and the same concentrations (2MIC, 1MIC and 1 / 2MIC drug concentrations were the same as those in Table 2 corresponding to gradients 6, 7, and 8) of luteolin and zinc acetate were used as control groups. The blank group was treated with saline, wherein the zinc-luteolin composite material was prepared according to the method in (I). The obtained bacterial suspension sample was placed in a 37°C shaker for 4h. The cultured bacterial suspension sample was taken out for centrifugation, the bacterial cells were washed 3 times with sterile saline, the bacterial cells were resuspended with 2.5% glutaraldehyde solution, and fixed in a 4°C refrigerator for 14h. The bacteria were washed three times with sterile saline, and then dehydrated for 10 min using different concentrations of ethanol (30%, 50%, 70%, 80%, 90% and 100%). The bacteria were resuspended in isoamyl acetate for 30 min. After drying in an oven, the samples were sprayed with gold and dotted on a stage covered with conductive glue and observed with a scanning electron microscope.
[0060] See also Figure 4 According to the scanning electron microscope images, the blank group's corresponding Salmonella enterica subspecies enteritidis serotype strain had a normal morphology, without shrinkage or deformation. As the concentration of the zinc-luteolin composite solution increased, the corresponding Salmonella enterica subspecies enteritidis serotype strain became deformed, leaked intracellular contents, and the number of bacterial deaths increased. The effects of luteolin and zinc acetate treatment at the same concentration showed that the bacterial morphology was relatively full, and the inhibitory effect was poorer than that of the zinc-luteolin composite solution.
[0061] (III) Study on the inhibitory mechanism of zinc-luteolin composite material on Salmonella enterica subspecies enteritidis serotype strains (membrane potential method)
[0062] Prepare the bacterial solution that has reached the logarithmic growth phase according to the process in 2.5, collect the bacterial cells by centrifugation, wash the bacterial cells with sterile physiological saline (i.e., the bacterial cell pellet obtained by centrifugation), and then add 1 mL of zinc-luteolin composite material solution with concentrations of 1 / 2MIC, 1MIC, and 2MIC to resuspend and serve as different concentrations of zinc-luteolin composite material treatment groups. At the same time, set up a blank group and a luteolin and zinc acetate control group. After culturing in a shaking incubator at 37°C for 4 hours, collect the bacterial cells by centrifugation, wash and resuspend, add 3 mM DiBAC4 (3) membrane potential fluorescent probe, incubate in the dark for 30 minutes, and pipette 200 μL into a black 96-well plate, with 5 parallels for each group. Use a multifunctional microplate reader to measure the fluorescence intensity (excitation wavelength = 492 nm, emission wavelength = 515 nm). Membrane potential refers to the potential difference between the inside and outside of a biological cell membrane.
[0063] Depend on Figure 5 It can be seen that compared with the blank group and the luteolin and zinc acetate control groups, the membrane potential of the Salmonella enterica serotype Enteritidis strain treated with the zinc-luteolin composite material for 4 hours was significantly increased; among them, the membrane potential of the blank group was -39185, the membrane potential of 1 / 2MIC was -3748, the membrane potential of 1MIC was 67122, and the membrane potential of 2MIC was 109196, which increased by 0.9 times, 2.7 times, and 3.79 times, respectively. This indicates that the zinc-luteolin composite material caused the depolarization of the cell membrane of the Salmonella enterica serotype Enteritidis strain in a dose-dependent manner, and the effect on the cell membrane surface potential of the Salmonella enterica serotype Enteritidis strain may change the activity of the sodium ion channel, resulting in increased influx and interference with the normal life activities of the bacteria.
[0064] (IV) Hepato-renal toxicity test of zinc-luteolin composite material
[0065] SPF grade 6-week-old male BLAB / C mice were selected, and the treatment of all animals in the experiment complied with the "Guidelines for the Care and Use of Laboratory Animals": ISBN-10:0-309-15396-4 (Eighth Edition) and "Regulations on Laboratory Animal Management of Shaanxi University of Science and Technology".
[0066] 20 SPF-grade 6-week-old female BLAB / C mice, weighing 18-20 grams, were allowed to eat and drink freely at 25°C. The bedding was changed every two days to ensure that the cages were dry and clean. The cages were wiped and disinfected with 75% anhydrous ethanol. The light was on for 12 hours a day, and 5 mice were fed in each cage. Before the experiment, adaptive feeding was performed for 7 days. The 20 mice were randomly divided into cages and divided into two groups. The body weight was measured every day during the adaptation period. The above 20 mice were divided into a zinc-luteolin composite material hepatotoxicity test group and a blank test group. According to the daily weight of the mice, the zinc-luteolin composite material hepatotoxicity test group was set to 2MIC concentration of drug solution for gavage, and the blank test group was gavaged with normal saline for 7 days.
[0067] On the 8th day of the experiment, mice were anesthetized by intraperitoneal injection of 3.5% chloral hydrate, and blood was collected from the eye sockets of the mice. The mice were killed by cervical dislocation, and the liver, kidney, spleen, jejunum, ileum, and colon of the mice were removed. The required parts were cut and added to 8mL of 4% paraformaldehyde solution, placed on a shaker and slowly shaken for 2 hours, and placed at room temperature for standby after fixation. The obtained samples were embedded in paraffin and sliced, and the paraffin sections were dewaxed and stained using an H&E staining kit (the specific process was: hematoxylin staining for 10 minutes, differentiation solution differentiation for 30 seconds, tap water soaking for 15 minutes, eosin staining for 1 minute, tap water soaking for 3 minutes, and naturally dried). The remaining tissues were placed in a 4% paraformaldehyde solution and fixed for more than 24 hours, and all the remaining tissues were quickly frozen in liquid nitrogen and stored in a -80°C refrigerator for standby use. The blood collected from each group was divided into two portions, one of which was placed in an anticoagulant tube for physiological and biochemical tests; the other blood was centrifuged at 4°C and 3000r / min for 10 minutes to separate the serum, discard the insoluble matter, transfer the serum to a clean test tube, and divide it into small portions and store it at -80°C.
[0068] According to the blood biochemical test, the relevant indicators of the zinc-luteolin composite material hepato-renal toxicity test group and the blank test group were not much different, and were all within the normal range. The H&E staining results showed that the tissue morphology of the organs in the zinc-luteolin composite material hepato-renal toxicity test group did not change significantly compared with the blank test group. Among them, no obvious damage was found in the liver, kidney, and spleen sections, and the tissue structure was normal ( Figure 6 ). Therefore, it can be concluded that the zinc-luteolin composite material has no hepatotoxicity and no effect on animal body weight and blood indicators, and is safe.
[0069] In summary, the zinc-luteolin composite material proposed in the present invention has the following advantages:
[0070] (1) Effectively inhibit bacterial growth: The zinc-luteolin composite material can inhibit the growth of Salmonella enterica subspecies enteritidis serotype in vitro (with a low MIC), thus achieving the antibacterial purpose. The zinc-luteolin complex, as its main component, is a product of metal phenolic acid complex, and has a better effect in preventing contamination and infection by Salmonella enterica subspecies enteritidis serotype.
[0071] (2) Zinc acetate is a common weak acid salt that is easy to obtain, widely available, and inexpensive. Luteolin is a natural product that can be extracted from plant raw materials or related processed products (such as peanut shells).
[0072] (3) Compared with traditional antibiotics, the zinc-luteolin composite material has the potential multi-target synergistic effect of zinc acetate and luteolin in antibacterial performance, is not easy to cause bacteria to develop drug resistance, and has the advantage of low toxicity.
[0073] The above advantages indicate that zinc-luteolin composite materials are expected to be used as medical antibacterial agents, food additives, and feed additives for antibacterial applications, and provide a new drug intervention approach to prevent related bacterial contamination and infection.
Claims
1. Application of a zinc-luteolin composite material in the preparation of a drug for inhibiting foodborne pathogens, characterized in that: The zinc-luteolin composite material inhibits the growth of Salmonella enteritidis.
2. The use according to claim 1, characterized in that: The enteritidis salmonella is enteritidis salmonella subspecies enteritidis serotype.
3. The use according to claim 2, characterized in that: The minimum inhibitory concentration of the zinc-luteolin composite material to Salmonella enterica subspecies enteritidis serotype is 31.25 μmol / L.
4. The use according to claim 2, characterized in that: The zinc-luteolin composite material causes depolarization of the cell membrane of the Salmonella enterica subspecies enteritidis serotype and causes damage to the cell membrane.
5. The use according to claim 2, characterized in that: The medicine also includes an effective component for resisting enteric Salmonella enterica subspecies enteritis serotype, which is compatible with the zinc-luteolin composite material.
6. The use according to claim 1 or 5, characterized in that: The medicine also includes preparation excipients.
7. Application of zinc-luteolin composite material in the preparation of food additives, characterized in that: The zinc-luteolin composite material inhibits the growth of Salmonella enteritidis.
8. The use according to claim 7, characterized in that: The enteritidis salmonella is enteritidis salmonella subspecies enteritidis serotype.
9. Application of zinc-luteolin composite material in the preparation of feed additives, characterized in that: The zinc-luteolin composite material inhibits the growth of Salmonella enteritidis.
10. The use according to claim 9, characterized in that: The enteritidis salmonella is enteritidis salmonella subspecies enteritidis serotype.
Citation Information
Cited By
Application of luteolin-zinc composite material in multi-target inhibition of valsa mali
CN121549360A
